Index of reports
> Cases with Neutropenia (138)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 138 Next >>
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-20
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Vincristine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Decadron Phosphate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Velcade
Dosage: day 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Cytarabine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Methotrexate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
PEG-Asparaginase
Dosage: day 2, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
End date: 2007-10-25
Doxil
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-14
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Pegaspargase
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
Vincristine
Dosage: 2 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Cytarabine
Dosage: 70 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-10-23
Methotrexate Sodium
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Decadron Phosphate
Dosage: 9 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Cytarabine side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08
Patient: 52 year old male
Reactions: Zygomycosis, Haemoptysis, Neck Pain, Chest Pain, Swelling, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 22.5 mg/m2
Indication: Acute Myeloid Leukaemia
Idarubicin Hydrochloride
Dosage: 6 mg/m2, 400 ug, intravenous, every two months
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 0.75 mg/m2
Indication: Acute Myeloid Leukaemia
Methylprednisolone
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in 66 year old male
Reported by a physician from France on 2012-08-07
Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Treanda
Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-27
End date: 2012-02-28
Melphalan Hydrochloride
Dosage: 250 mg total dose
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-03
Cytarabine
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Etoposide
Dosage: 400 mg/m2 daily; uid/qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Treanda
Indication: non-Hodgkin's Lymphoma
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-02
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Neutropenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, qd; day 1 to 5; cycles i and ii
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin; Voriconazole
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-05
Patient: male, weighing 98.5 kg (216.7 pounds)
Reactions: Dyspnoea, Pyrexia, Legionella Infection, Neutropenia, Lobar Pneumonia, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 39600 mg
End date: 2012-06-10
Daunorubicin HCL
Dosage: 381 mg
End date: 2012-03-26
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from China on 2012-07-02
Patient:
Reactions: Thrombocytosis, NO Therapeutic Response, Febrile Neutropenia, Bone Marrow Failure, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cytarabine
Dosage: 10 mg/m2, in 1 cyclical
Indication: Myeloid Leukaemia
Cytarabine
Dosage: 10 mg/m2, in 1 cyclical
Indication: Myelodysplastic Syndrome
Decitabine
Dosage: 15 mg/m2, in 1 cyclical, intravenous
Indication: Myeloid Leukaemia
Aclarubicin (Aclarubicin) Unspecified
Dosage: 10 mg, in 1 cyclical
Indication: Myeloid Leukaemia
Aclarubicin (Aclarubicin) Unspecified
Dosage: 10 mg, in 1 cyclical
Indication: Myelodysplastic Syndrome
Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
Indication: Myelodysplastic Syndrome
Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
Indication: Myeloid Leukaemia
Other drugs received by patient: Hydroxyurea; Homoharringtonine (Homoharringtonine)
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-02
Patient: male, weighing 98.5 kg (216.7 pounds)
Reactions: Pneumonia, Pyrexia, Neutropenia, Legionella Infection, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-06-28
Patient: female, weighing 44.5 kg (97.9 pounds)
Reactions: Hypotension, Pyrexia, Abdominal Pain Upper, Candida Test Positive, Simplex Virus Test Positive, Diarrhoea, Fungal Test Positive, Skin Lesion, Neutropenia, Klebsiella Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-L-Asparaginase (K-H)
Dosage: 3225 unit
Cytarabine
Dosage: 70 mg
Vincristine Sulfate
Dosage: 3.88 mg
Methylprednisolone
Dosage: 813.75 mg
Methotrexate
Dosage: 15 mg
Possible Cytarabine side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-27
Patient:
Reactions: Blood Bilirubin Increased, Vomiting, Nausea, Anaemia, Rash, Fatigue, Aspartate Aminotransferase Increased, Adverse Event, Neutropenia, Rash Maculo-Papular, Thrombocytopenia, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Administration route: Oral
Revlimid
Dosage: 10mg-25mg
Administration route: Oral
Revlimid
Dosage: 50 milligram
Administration route: Oral
Revlimid
Dosage: 10mg-25mg
Administration route: Oral
Cytarabine
Dosage: 1.5 milligram/sq. meter
Cytarabine
Dosage: 10 milligram
Possible Cytarabine side effects in 14 year old male
Reported by a physician from Norway on 2012-06-22
Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Arachnoiditis, Deafness, Pyrexia, Somnolence, Fall, Mucosal Inflammation, Fatigue, C-Reactive Protein Increased, Neutropenia, Sinusitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Celecoxib
Dosage: 800 milligram
Administration route: Oral
Indication: Medulloblastoma
Celecoxib
Dosage: 100 milligram
Administration route: Oral
Thalidomide
Dosage: 50 milligram
Administration route: Oral
Cytarabine
Cytarabine
Indication: Medulloblastoma
Etoposide
Dosage: 100 milligram
Administration route: Oral
Indication: Medulloblastoma
Etoposide
Dosage: 12.5 milligram
Administration route: Oral
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Indication: Medulloblastoma
Other drugs received by patient: Prednisolone Succinate; Dexamethasone; Dexamethasone
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from Italy on 2012-06-18
Patient: male
Reactions: Epstein-Barr Virus Infection, Diarrhoea, Anaemia, Sepsis, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Vincristine Sulfate
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Cisplatin
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Mabthera
Indication: Burkitt's Lymphoma
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Possible Cytarabine side effects in male
Reported by a physician from Italy on 2012-06-14
Patient: male
Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection
Drug(s) suspected as cause:
Carmustine
Indication: Burkitt's Lymphoma
Carboplatin
Indication: Burkitt's Lymphoma
Rituximab
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Melphalan Hydrochloride
Indication: Burkitt's Lymphoma
Radiotherapy
Indication: Burkitt's Lymphoma
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cisplatin
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Ifosfamide
Indication: Burkitt's Lymphoma
Granulocyte Colony Stimulating Factor
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Burkitt's Lymphoma
Unknown Medication
Dosage: antimicrobial prophylaxis
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication
Possible Cytarabine side effects in 14 year old male
Reported by a physician from Norway on 2012-06-12
Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Arachnoiditis, Deafness, Pyrexia, Fall, Somnolence, Mucosal Inflammation, Fatigue, Neutropenia, Sinusitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Thalidomide
Dosage: 50 milligram
Administration route: Oral
Celecoxib
Dosage: 800 milligram
Administration route: Oral
Indication: Medulloblastoma
Cytarabine
Indication: Medulloblastoma
Etoposide
Dosage: 12.5 milligram
Administration route: Oral
Cytarabine
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Indication: Medulloblastoma
Etoposide
Dosage: 100 milligram
Administration route: Oral
Indication: Medulloblastoma
Celecoxib
Dosage: 100 milligram
Administration route: Oral
Other drugs received by patient: Prednisolone Succinate; Dexamethasone; Dexamethasone
Possible Cytarabine side effects in 17 year old female
Reported by a physician from United States on 2012-06-08
Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)
Reactions: Blood Bilirubin Increased, Pyrexia, Caecitis, Loss of Consciousness, Oedema Peripheral, Pulmonary Oedema, Hypocalcaemia, Acute Respiratory Distress Syndrome, Melaena, Hypertriglyceridaemia, Epistaxis, Dysphagia, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Eating Disorder, Tremor, Cerebral Infarction, Depressed Level of Consciousness, Neutropenia, Confusional State, Dyskinesia, Somnolence, Splenic Infarction, Hypokalaemia, Pleural Effusion, White Blood Cell Count Decreased, Cerebrovascular Accident, Ascites, Diarrhoea, Hypophagia, Hypoalbuminaemia, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Oncaspar
Indication: T-Cell Type Acute Leukaemia
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-04-13
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Dalteparin Sodium
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Nystatin; Lansoprazole; Insulin Aspart; Piperacillin and Tazobactam; Vancomycin; Voriconazole
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-06-05
Patient: female
Reactions: Neutropenia, Device Related Infection, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: itrc
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-23
End date: 2012-04-23
Dasatinib
Dosage: 45 milligram;
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-30
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-16
Daunorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-30
Dexamethasone
Dosage: 2/1 day
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-29
Pegaspargase
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-19
End date: 2012-04-19
Vincristine
Dosage: 7 day
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-30
Other drugs received by patient: Furosemide; Nystatin; Zantac; Ondansetron
Possible Cytarabine side effects in 38 year old female
Reported by a physician from United States on 2012-06-01
Patient: 38 year old female
Reactions: Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Mesna
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Dasatinib
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Possible Cytarabine side effects in
Reported by a individual with unspecified qualification from France on 2012-05-31
Patient:
Reactions: Lung Neoplasm Malignant, Richter's Syndrome, Pancytopenia, Neutropenia, Hodgkin's Disease, Sarcoma Uterus
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Indication: B-Cell Lymphoma
Cisplatin
Indication: B-Cell Lymphoma
Mabthera
Indication: B-Cell Lymphoma
Fludarabine Phosphate
Indication: B-Cell Lymphoma
Oxaliplatin
Indication: B-Cell Lymphoma
Dexamethasone
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: B-Cell Lymphoma
Possible Cytarabine side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 52 year old male
Reactions: Haemoptysis, Acute Myeloid Leukaemia, Myelodysplastic Syndrome Transformation, Local Swelling, Hypokalaemia, Pneumonia Cytomegaloviral, Pulmonary Haemorrhage, Zygomycosis, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Idarubicin HCL
Idarubicin HCL
Dosage: 6 milligram/sq. meter
Indication: Myelodysplastic Syndrome
Cytarabine
Vidaza
Indication: Myelodysplastic Syndrome
Cytarabine
Dosage: 6 g/m2
Indication: Myelodysplastic Syndrome
Vidaza
Clofarabine
Dosage: 22.5 milligram/sq. meter
Indication: Myelodysplastic Syndrome
Other drugs received by patient: Fluconazole; Ciprofloxacin; Acyclovir; Metformin HCL; Insulin
Possible Cytarabine side effects in female
Reported by a physician from Spain on 2012-05-11
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Bacteraemia, Neutropenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Evoltra
Dosage: 33 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2011-04-13
End date: 2011-04-17
Cytarabine
Dosage: 33 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2011-04-13
End date: 2011-04-26
Other drugs received by patient: Mycostatin; Meropenem; Enalapril Maleate; Metoclopramide; Scopolamine; Acyclovir; Pantoprazole; Chlorhexidine Gluconate; Furosemide
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from United States on 2012-05-08
Patient: male, weighing 15.9 kg (35.0 pounds)
Reactions: Cerebral Aspergillosis, Brain Stem Syndrome, Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Daunorubicin Hydrochloride
Dosage: 34 mg
End date: 2012-04-04
Cytarabine
Dosage: 70 mg
End date: 2012-03-27
Dexamethasone
Dosage: 81 mg
End date: 2012-04-08
Other drugs received by patient: PEG-L Asparaginase (Pegaspargase, Oncospar); Vincristine Sulfate; Methotrexate
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-03
Patient:
Reactions: Bronchopulmonary Aspergillosis, Pneumonia Fungal, Respiratory Disorder, Lung Neoplasm, Chronic Lymphocytic Leukaemia Transformation, Malignant Lymphoma Unclassifiable High Grade, Neutropenia, Immunosuppression
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Indication: Chronic Lymphocytic Leukaemia
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Cytarabine
Indication: Chronic Lymphocytic Leukaemia
Carmustine
Indication: Chronic Lymphocytic Leukaemia
Fludarabine Phosphate
Indication: Chronic Lymphocytic Leukaemia
(Rituximab)
Indication: Chronic Lymphocytic Leukaemia
Prednisolone
Indication: Chronic Lymphocytic Leukaemia
Etoposide
Indication: Chronic Lymphocytic Leukaemia
(Chlorambucil)
Indication: Chronic Lymphocytic Leukaemia
Possible Cytarabine side effects in female
Reported by a physician from United Kingdom on 2012-05-03
Patient: female
Reactions: Eye Infection Toxoplasmal, Neutropenia, Uveitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Etoposide
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-09
End date: 2011-11-29
Cytarabine
Dosage: unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-09
End date: 2011-11-29
Everolimus
Dosage: unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-09
End date: 2011-11-29
Daunorubicin Hydrochloride
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-09
End date: 2011-11-29
Other drugs received by patient: Ondansetron; Codeine; Vancomycin; Bisacodyl; Fluconazole; Docusate Sodium; Citalopram; Citalopram; Cyclizine; Phosphate-Sandoz; Metamucil-2; Zopiclone; Posaconazole; Nilstat; Pyrimethamine TAB; Acyclovir; Slow-K; Granulocyte Colony Stimulating Factor; Sulphadiazine; Scopolamine
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-03
Patient:
Reactions: Bronchopulmonary Aspergillosis, Pneumonia Fungal, Respiratory Disorder, Lung Neoplasm, Malignant Lymphoma Unclassifiable High Grade, Neutropenia, Immunosuppression
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Carmustine
Indication: Chronic Lymphocytic Leukaemia
Etoposide
Indication: Chronic Lymphocytic Leukaemia
(Rituximab)
Indication: Chronic Lymphocytic Leukaemia
(Chlorambucil)
Indication: Chronic Lymphocytic Leukaemia
Prednisolone
Indication: Chronic Lymphocytic Leukaemia
Fludarabine Phosphate
Indication: Chronic Lymphocytic Leukaemia
Melphalan Hydrochloride
Indication: Chronic Lymphocytic Leukaemia
Cytarabine
Indication: Chronic Lymphocytic Leukaemia
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-04-27
Patient:
Reactions: Pancytopenia, Febrile Neutropenia, Mantle Cell Lymphoma, Disease Progression, Mucosal Inflammation, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Tositumomab-Iodine 131
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Indication: Mantle Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Mantle Cell Lymphoma
Tositumomab-Iodine 131
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Mantle Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-24
Patient:
Reactions: Pancytopenia, Febrile Neutropenia, Mantle Cell Lymphoma, Disease Progression, Mucosal Inflammation, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Cytarabine
Indication: Mantle Cell Lymphoma
Etoposide
Indication: Mantle Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Tositumomab-Iodine 131
Indication: Mantle Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Mantle Cell Lymphoma
Rituximab
Indication: Mantle Cell Lymphoma
Tositumomab-Iodine 131
Indication: Diffuse Large B-Cell Lymphoma
Possible Cytarabine side effects in 14 year old male
Reported by a individual with unspecified qualification from Norway on 2012-04-23
Patient: 14 year old male
Reactions: Stomatitis, Ataxia, Febrile Neutropenia, Cognitive Disorder, Dysarthria, Neurotoxicity, Fatigue, Visual Impairment, Hypothyroidism, Coordination Abnormal, Neutropenia, Sinusitis
Drug(s) suspected as cause:
Temozolomide
Indication: Medulloblastoma
Exitop Kapsler 100 MG
Indication: Medulloblastoma
Lomustine
Indication: Medulloblastoma
Cisplatin
Indication: Medulloblastoma
Carboplatin
Indication: Medulloblastoma
Sendoxan 1000 MG Pulver TIL Injeksjonsv?ske, Oppl?sning
Indication: Medulloblastoma
Celecoxib
Administration route: Oral
Indication: Medulloblastoma
Cytarabine
Indication: Medulloblastoma
Vincristine Sulfate
Indication: Medulloblastoma
Thalidomide
Administration route: Oral
Indication: Medulloblastoma
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-04-12
Patient:
Reactions: Nausea, Haemorrhage, Pain, Rash, Pyrexia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Revlimid
Dosage: 5mg escalated in 5mg increments to 25mg/day max
Administration route: Oral
Cytarabine
Dosage: 100 milligram/sq. meter
Idarubicin HCL
Dosage: 12 milligram/sq. meter
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-04-11
Patient: female, weighing 19.1 kg (42.0 pounds)
Reactions: Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Pyrexia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 24 mg
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: 1750 iu
Cytarabine
Dosage: 70 mg
Vincristine Sulfate
Dosage: 4.2 mg
Dexamethasone
Dosage: 108 mg
Other drugs received by patient: Ranitidine; Mirilax; Trimethoprim + Sulfamethoxazole; Lactulose; Acetaminaphen-Codeine; Gabapentin
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-04-11
Patient: female, weighing 65.8 kg (144.8 pounds)
Reactions: Pneumonia, Pseudomonal Sepsis, Neutropenia, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 5-25mg
Administration route: Oral
Idarubicin HCL
Dosage: 12 milligram/sq. meter
Cytarabine
Dosage: 100 milligram/sq. meter
Revlimid
Dosage: 20 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-08-30
Other drugs received by patient: Metoprolol Tartrate; Bumex; Filgrastim; Acyclovir; Allopurinol; Bumex; Docusate; Lunesta; Tylenol (Caplet); Loperamide; Albumin (Human); FAT Emulsion; Loratadine; Magnesium Oxide; Metoprolol Tartrate; Clarinex; Hydrocortisone; Regular Insulin; Dextrose; Piperacillin and Tazobactam; Potassium Chloride; Fluticasone Furoate; Nexium; TPN; Hydroxyzine; Simethicone; Simethicone; Vesicare; Pantoprazole
Page 1 Next >>
|